Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 8376 - 8400 of 10282 in total
Experimental
Matched Iupac: … 4-oxopentanoic acid …
Experimental
Matched Iupac: … (4-bromophenyl)methanol …
Phenacetin was withdrawn from the Canadian market in June 1973 due to concerns regarding nephropathy (damage to or disease of the kidney).
Withdrawn
Matched Iupac: … N-(4-ethoxyphenyl)acetamide …
Experimental
Matched Iupac: … [4-(carbamimidoylsulfanyl)butyl]dimethylamine …
Vanillyl alcohol has been used in trials studying the treatment of Smoking.
Investigational
Matched Iupac: … 4-(hydroxymethyl)-2-methoxyphenol …
Aminomethylbenzoic acid may be useful as an antifibrinolytic agent .
Experimental
Matched Iupac: … 4-(aminomethyl)benzoic acid …
Experimental
Matched Iupac: … diethyl 4-nitrophenyl phosphate …
Experimental
Matched Iupac: … 4-chlorobenzene-1,3-disulfonamide …
Experimental
Matched Iupac: … N-(4-aminobenzenesulfonyl)guanidine …
Experimental
Vet approved
Matched Iupac: … 4-(dimethylamino)-2,2-diphenylpentanamide …
Sovaprevir has been investigated for the treatment of Hepatitis C, Chronic.
Investigational
Matched Iupac: … ]-2-ethenylcyclopropyl]-4-[(7-methoxy-2-phenylquinolin-4-yl)oxy]pyrrolidine-2-carboxamide ... (2S,4R)-1-[(2S)-2-tert-butyl-4-oxo-4-(piperidin-1-yl)butanoyl]-N-[(1R,2S)-1-[(cyclopropanesulfonyl)carbamoyl …
Pinometostat has been used in trials studying the treatment of Leukemia, Acute Leukemias, Acute Myeloid Leukemia, Myelodysplastic Syndrome, and Acute Lymphocytic Leukemia, among others.
Investigational
CYNK-101 is an allogeneic human placental hematopoietic stem cell-derived natural killer (NK) cell therapy product that is genetically modified to express a variant of CD16 (CD16VP).
Investigational
Experimental
Illicit
Matched Iupac: … ethyl 1-{2-[(oxolan-2-yl)methoxy]ethyl}-4-phenylpiperidine-4-carboxylate …
Experimental
Matched Iupac: … (2R)-2-[(E)-N''-[(4S)-4-amino-4-carboxybutyl]carbamimidamido]butanedioic acid …
Experimental
Matched Iupac: … (2S)-2-acetamido-3-[4-(4-hydroxy-3,5-dinitrophenoxy)phenyl]propanoic acid …
Experimental
Matched Iupac: … 2,2-dichloro-N-(2-hydroxyethyl)-N-{[4-(4-nitrophenoxy)phenyl]methyl}acetamide …
AIM-102 is under investigation in clinical trial NCT01501942 (Efficacy, Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Oral Administration of AIM-102 in Patients With Mild to Moderate Allergic Asthma).
Investigational
Matched Iupac: … (4R)-4-[(2R)-2-amino-3-cyclohexylpropanamido]-4-[(carboxymethyl)carbamoyl]butanoic acid …
Experimental
Illicit
Matched Iupac: … 1-methyl-4-phenyl-3-(prop-2-en-1-yl)piperidin-4-yl propanoate …
Experimental
Matched Iupac: … (2R)-N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorobenzenesulfonyl)-2-hydroxy-2-methylpropanamide …
Clinofibrate is a fibrate drug sold and marketed in Japan.
Experimental
Matched Iupac: … 2-(4-{1-[4-(1-carboxy-1-methylpropoxy)phenyl]cyclohexyl}phenoxy)-2-methylbutanoic acid …
Enobosarm has been used in trials studying the treatment of Stress Urinary Incontinence and Triple Negative Breast Cancer.
Investigational
Matched Iupac: … (2S)-N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide …
Displaying drugs 8376 - 8400 of 10282 in total